SCHEMBL27722396

SCHEMBL27722396

CCc1cccc2nc(-c3ncc[nH]3)c(NCC(=O)NO)n12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PDE5A O76074 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
F2RL1 P55085 2/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30
PDE4C Q08493 1/20 0.30
PDE4D Q08499 1/20 0.30
MMP1 P03956 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27701922 0.88 GAA (0.39) KDM4EALDH1A1MEN1TP53GAA
SCHEMBL27701766 0.78 GRIN1 (0.34) KDM4EALDH1A1PDE5AGAAMAPT
SCHEMBL27701833 0.78 HDAC1 (0.35) KDM4EALDH1A1PDE5AGAA
SCHEMBL27722332 0.77 NR1H4 (0.41) KDM4EALDH1A1ADORA2AADORA1F2RL1
SCHEMBL27701908 0.76 GRIN1 (0.33) ALDH1A1PDE5ANPC1GAARAB9A
SCHEMBL27701657 0.76 HDAC1 (0.36)
SCHEMBL27701635 0.74 HDAC1 (0.33) SMN1; SMN2PDE4A
SCHEMBL27701656 0.74 MCHR1 (0.32) KDM4EALDH1A1GAA
SCHEMBL27722379 0.74 GRIN1 (0.32)
SCHEMBL27701827 0.74 HDAC1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101163703-B Imidazo [1,2-A ] pyridine derivatives as Peptide Deformylase (PDF) inhibitors NOVARTIS AG 2010-12-15 CN disclosed
CN-101163703-A Imidazo [1, 2-A ] pyridine derivatives as Peptide Deformylase (PDF) inhibitors NOVARTIS AG (CH) 2008-04-16 CN disclosed